Xiaolu Jiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaolu Jiao has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Fumin Lei
State Key Laboratory of Animal Biodiversity Conservation and Integrated Pest Management, Institute of Zoology, Chinese Academy of Sciences, Beijing, China
2 shared publications - Juan Li
The Second Affiliated Hospital of Chongqing Medical University, Department of Gastroenterology, Chongqing, China
2 shared publications - Yanwen Qin
Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China
2 shared publications - Yuan-Han Yang
Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology, Guangdong Provincial Engineering Research Center for Ambient Mass Spectrometry, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou, 510070, China
2 shared publications Aitao Liu
Colorado State University Department of Biology Fort Collins
1 shared publicationAndrea Bours
Max Planck Institute for Evolutionary Biology , Plön
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in Evolution Letters
- Vol. 10 (4) , 396-412
Migration patterns and hybridization within the Asian stonechat complex in response to a major geographical barrier
Facing geographical barriers, phenotypic responses of migratory landbirds may differ even between closely related taxa: some may bypass barriers while others cross them. Such phenotypic variation can arise from different genetic backgrounds and lead to different adaptive processes. A classic example is migratory divide, i.e., breeding ranges where different migration-route phenotypes co-exist or meet. Such variation can facilitate an understanding of the evolutionary background of migration and responses to barriers. In Asia, a migratory divide has been suggested in response to the major landscape, the Qinghai-Tibet Plateau (QTP) for 2 stonechat taxa (Siberian stonechat Saxicola maurus maurus and Amur stonechat S. stejnegeri). Detouring along either side of the QTP, these taxa are believed to disfavor crossing over the highland. However, the Tibetan stonechat (S. m. przewalskii), breeding on the QTP, may differ in its barrier response due to possible adaptation to high elevation. To investigate migration patterns and potentially associated genetic differences, we studied migration routes and population genetics of populations around the assumed migratory divide in Russia and Mongolia and of a Chinese population from the QTP. Our results confirmed the existence of a migratory divide between maurus and stejnegeri, albeit with extensive hybridization over generations. Of the 3 genotyped individuals employing intermediate routes across the QTP, 2 were clear hybrids. Meanwhile, przewalskii consistently followed a highland-crossing route and was genetically differentiated from maurus and stejnegeri. The diverse migration routes indicate that Asian stonechats respond differently to the geographical barrier. The partly viable intermediate route may be associated with hybridization and potentially facilitating gene flow between maurus and stejnegeri. The Asian stonechat complex thus offers great opportunities for research, with its specific evolutionary background associated with inhabiting and crossing the QTP, offering novel perspectives on the genetics and evolution of migration.
- 5 May 2026
- Published by Oxford University Press (OUP) in Evolution Letters
- Vol. 10 (4) , 396-412
Open AccessMigration patterns and hybridization within the Asian stonechat complex in response to a major geographical barrier
Facing geographical barriers, phenotypic responses of migratory landbirds may differ even between closely related taxa: some may bypass barriers while others cross them. Such phenotypic variation can arise from different genetic backgrounds and lead to different adaptive processes. A classic example is migratory divide, i.e., breeding ranges where different migration-route phenotypes co-exist or meet. Such variation can facilitate an understanding of the evolutionary background of migration and responses to barriers. In Asia, a migratory divide has been suggested in response to the major landscape, the Qinghai-Tibet Plateau (QTP) for 2 stonechat taxa (Siberian stonechat Saxicola maurus maurus and Amur stonechat S. stejnegeri). Detouring along either side of the QTP, these taxa are believed to disfavor crossing over the highland. However, the Tibetan stonechat (S. m. przewalskii), breeding on the QTP, may differ in its barrier response due to possible adaptation to high elevation. To investigate migration patterns and potentially associated genetic differences, we studied migration routes and population genetics of populations around the assumed migratory divide in Russia and Mongolia and of a Chinese population from the QTP. Our results confirmed the existence of a migratory divide between maurus and stejnegeri, albeit with extensive hybridization over generations. Of the 3 genotyped individuals employing intermediate routes across the QTP, 2 were clear hybrids. Meanwhile, przewalskii consistently followed a highland-crossing route and was genetically differentiated from maurus and stejnegeri. The diverse migration routes indicate that Asian stonechats respond differently to the geographical barrier. The partly viable intermediate route may be associated with hybridization and potentially facilitating gene flow between maurus and stejnegeri. The Asian stonechat complex thus offers great opportunities for research, with its specific evolutionary background associated with inhabiting and crossing the QTP, offering novel perspectives on the genetics and evolution of migration.
- Open Access
- 6 February 2024
- Published by Oxford University Press (OUP) in Molecular Biology and Evolution
- Vol. 41 (3)
Landscape Heterogeneity Explains the Genetic Differentiation of a Forest Bird across the Sino-Himalayan Mountains
Mountains are the world's most important centers of biodiversity. The Sino-Himalayan Mountains are global biodiversity hotspot due to their extremely high species richness and endemicity. Ample research investigated the impact of the Qinghai–Tibet Plateau uplift and Quaternary glaciations in driving species diversification in plants and animals across the Sino-Himalayan Mountains. However, little is known about the role of landscape heterogeneity and other environmental features in driving diversification in this region. We utilized whole genomes and phenotypic data in combination with landscape genetic approaches to investigate population structure, demography, and genetic diversity in a forest songbird species native to the Sino-Himalayan Mountains, the red-billed leiothrix (Leiothrix lutea). We identified 5 phylogeographic clades, including 1 in the East of China, 1 in Yunnan, and 3 in Tibet, roughly consistent with differences in song and plumage coloration but incongruent with traditional subspecies boundaries. Isolation-by-resistance model best explained population differentiation within L. lutea, with extensive secondary contact after allopatric isolation leading to admixture among clades. Ecological niche modeling indicated relative stability in the extent of suitable distribution areas of the species across Quaternary glacial cycles. Our results underscore the importance of mountains in the diversification of this species, given that most of the distinct genetic clades are concentrated in a relatively small area in the Sino-Himalayan Mountain region, while a single shallow clade populates vast lower-lying areas to the east. This study highlights the crucial role of landscape heterogeneity in promoting differentiation and provides a deep genomic perspective on the mechanisms through which diversity hotspots form.
- 6 February 2024
- Published by Oxford University Press (OUP) in Molecular Biology and Evolution
- Vol. 41 (3)
Open AccessLandscape Heterogeneity Explains the Genetic Differentiation of a Forest Bird across the Sino-Himalayan Mountains
Mountains are the world's most important centers of biodiversity. The Sino-Himalayan Mountains are global biodiversity hotspot due to their extremely high species richness and endemicity. Ample research investigated the impact of the Qinghai–Tibet Plateau uplift and Quaternary glaciations in driving species diversification in plants and animals across the Sino-Himalayan Mountains. However, little is known about the role of landscape heterogeneity and other environmental features in driving diversification in this region. We utilized whole genomes and phenotypic data in combination with landscape genetic approaches to investigate population structure, demography, and genetic diversity in a forest songbird species native to the Sino-Himalayan Mountains, the red-billed leiothrix (Leiothrix lutea). We identified 5 phylogeographic clades, including 1 in the East of China, 1 in Yunnan, and 3 in Tibet, roughly consistent with differences in song and plumage coloration but incongruent with traditional subspecies boundaries. Isolation-by-resistance model best explained population differentiation within L. lutea, with extensive secondary contact after allopatric isolation leading to admixture among clades. Ecological niche modeling indicated relative stability in the extent of suitable distribution areas of the species across Quaternary glacial cycles. Our results underscore the importance of mountains in the diversification of this species, given that most of the distinct genetic clades are concentrated in a relatively small area in the Sino-Himalayan Mountain region, while a single shallow clade populates vast lower-lying areas to the east. This study highlights the crucial role of landscape heterogeneity in promoting differentiation and provides a deep genomic perspective on the mechanisms through which diversity hotspots form.
- Open Access
- 29 March 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-10
Circulating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea
Background and Aims. Obstructive sleep apnea (OSA) is strongly associated with obesity, metabolic diseases, coronary artery disease (CAD), stroke, hypertension, and other disorders. This study assessed the relationship between circulating a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS13) levels and the presence of OSA. Materials and Methods. This cross-sectional study included a total of 223 patients. We used a powerful high-throughput multiplexed immunobead-based assay to detect circulating levels of ADAMTS13. The associations between circulating ADAMTS13 levels and OSA were evaluated by multivariate logistic regression analysis. Results. Circulating ADAMTS13 levels were significantly elevated in patients with OSA compared with controls (0.8 vs. 2.7 μg/mL, respectively, ). After adjusting for confounding factors, circulating ADAMTS13 levels were significantly independently associated with the presence of OSA ( , 95% confidence interval (CI) =4.11–24.13, ). Furthermore, circulating ADAMTS13 levels showed discriminatory accuracy in assessing the presence of OSA (area under the curve: 0.87, 95% CI 0.81–0.93, ). Conclusion. Circulating ADAMTS13 levels were significantly correlated with the presence of OSA. ADAMTS13 may therefore function as a novel biomarker for monitoring the development and progression of OSA.
- 29 March 2022
- Published by Wiley in Disease Markers
- Vol. 2022, 1-10
Open AccessCirculating ADAMTS13 Levels Are Associated with an Increased Occurrence of Obstructive Sleep Apnea
Background and Aims. Obstructive sleep apnea (OSA) is strongly associated with obesity, metabolic diseases, coronary artery disease (CAD), stroke, hypertension, and other disorders. This study assessed the relationship between circulating a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13 (ADAMTS13) levels and the presence of OSA. Materials and Methods. This cross-sectional study included a total of 223 patients. We used a powerful high-throughput multiplexed immunobead-based assay to detect circulating levels of ADAMTS13. The associations between circulating ADAMTS13 levels and OSA were evaluated by multivariate logistic regression analysis. Results. Circulating ADAMTS13 levels were significantly elevated in patients with OSA compared with controls (0.8 vs. 2.7 μg/mL, respectively, ). After adjusting for confounding factors, circulating ADAMTS13 levels were significantly independently associated with the presence of OSA ( , 95% confidence interval (CI) =4.11–24.13, ). Furthermore, circulating ADAMTS13 levels showed discriminatory accuracy in assessing the presence of OSA (area under the curve: 0.87, 95% CI 0.81–0.93, ). Conclusion. Circulating ADAMTS13 levels were significantly correlated with the presence of OSA. ADAMTS13 may therefore function as a novel biomarker for monitoring the development and progression of OSA.
- Open Access
- 1 July 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota
Chronic intermittent hypoxia (CIH) is the prominent signature of highly prevalent obstructive sleep apnea (OSA) pathophysiology, which leads to increased risk and aggravation of atherosclerotic cardiovascular diseases. However, whether intestinal microbiota is implicated in the mechanisms linking CIH to arteriosclerosis (AS) pathogenesis remains unclear. The association of CIH with the development of altered gut microbiota (GM) may provide the opportunity to develop preventive strategies for atherosclerotic cardiovascular risk reduction. Animal models of apolipoprotein E-deficient (apoE-/-) mice treated with high-fat diet (HFD) and subjected to CIH conditions was applied to mimic the AS observed in patients with OSA. The physiological status and atherosclerotic lesion formation were confirmed by histological analysis. 16S rDNA sequencing of fecal samples was conducted to determine the changes in gut microbial composition. Morphometric analysis demonstrated that CIH caused aggravated atherosclerotic lesions and facilitated AS in apoE-/- mice treated with HFD. The gut bacteria was significantly varied in AS and AS+CIH mice compared with that in the control mice. Significantly perturbed GM profiles were detected in AS mice with and without CIH, with altered microbial α- and β- diversity and shifts in bacterial compositions at phylum and genus levels. While the difference between AS and AS+CIH was observed at different bacteria taxa levels. Aggravation of reduced Sutterella and increased Halomonas, Halomonadaceae and Oceanospirillales was noted in CIH-treated AS mice. The correlation of intestinal bacterial parameters with pathological changes in artery indicated complicated interactions under CIH-induced GM dysbiosis. Furthermore, the gut microbial functions in the potential ability of replication recombination and repair proteins, glycan biosynthesis and metabolism, as well as metabolism of cofactors and vitamins were identified to be further suppressed by CIH. Our findings demonstrated a causal effect of CIH on GM alterations in AS mice and suggested that the disordered GM features in AS development were deteriorated by CIH, which may be associated with AS aggravation. Preventative strategies targeting gut microbiome are highly recommended for intervention of OSA-related AS.
- 1 July 2021
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Open AccessChronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota
Chronic intermittent hypoxia (CIH) is the prominent signature of highly prevalent obstructive sleep apnea (OSA) pathophysiology, which leads to increased risk and aggravation of atherosclerotic cardiovascular diseases. However, whether intestinal microbiota is implicated in the mechanisms linking CIH to arteriosclerosis (AS) pathogenesis remains unclear. The association of CIH with the development of altered gut microbiota (GM) may provide the opportunity to develop preventive strategies for atherosclerotic cardiovascular risk reduction. Animal models of apolipoprotein E-deficient (apoE-/-) mice treated with high-fat diet (HFD) and subjected to CIH conditions was applied to mimic the AS observed in patients with OSA. The physiological status and atherosclerotic lesion formation were confirmed by histological analysis. 16S rDNA sequencing of fecal samples was conducted to determine the changes in gut microbial composition. Morphometric analysis demonstrated that CIH caused aggravated atherosclerotic lesions and facilitated AS in apoE-/- mice treated with HFD. The gut bacteria was significantly varied in AS and AS+CIH mice compared with that in the control mice. Significantly perturbed GM profiles were detected in AS mice with and without CIH, with altered microbial α- and β- diversity and shifts in bacterial compositions at phylum and genus levels. While the difference between AS and AS+CIH was observed at different bacteria taxa levels. Aggravation of reduced Sutterella and increased Halomonas, Halomonadaceae and Oceanospirillales was noted in CIH-treated AS mice. The correlation of intestinal bacterial parameters with pathological changes in artery indicated complicated interactions under CIH-induced GM dysbiosis. Furthermore, the gut microbial functions in the potential ability of replication recombination and repair proteins, glycan biosynthesis and metabolism, as well as metabolism of cofactors and vitamins were identified to be further suppressed by CIH. Our findings demonstrated a causal effect of CIH on GM alterations in AS mice and suggested that the disordered GM features in AS development were deteriorated by CIH, which may be associated with AS aggravation. Preventative strategies targeting gut microbiome are highly recommended for intervention of OSA-related AS.
- 28 May 2019
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 25 (2) , 190-200
ANGPTL3 Mutations in Unrelated Chinese Han Patients with Familial Hypercholesterolemia
Background and objective: Familial hypercholesterolemia (FH) is a severe genetic hyperlipidemia characterized by increased levels of low-density lipoprotein cholesterol (LDL-C), leading to premature atherosclerosis. Angiopoietin-like protein (ANGPTL3) is a hepatocyte-specific protein that can be used to lower LDL in FH. However, it was unknown whether ANGPTL3 variants are present in FH patients. This study was performed to identify ANGPTL3 variants in unrelated Chinese Han patients with FH. Methods and Results: We screened 80 patients with FH (total cholesterol >7.8mmol/L, LDL-cholesterol >4.9mmol/L) and 77 controls using targeted next-generation sequencing (NGS) of six FH candidate genes (LDLR, ApoB100, PCSK9, ABCG5, ABCG8, and ANGPTL3). Candidate pathogenic variants identified by NGS were validated by Sanger sequencing. Mutant and wild-type plasmids containing the variant sequence were constructed and verified by Sanger sequencing. The gene expression profile was analyzed by an expression profile chip in transfected HepG2 cells using quantitative real-time (qRT)-PCR. We identified 41 variants in 28 FH patients, including two ANGPTL3 mutations: one exonic (c.A956G: p.K319R) and one in the untranslated region (c.*249G>A). Gene ontology analyses found that the cholesterol metabolic process and ANGPTL3 expression were significantly up-regulated in the ANGPTL3 K319R mutation group compared with the wild-type group. qRT-PCR findings were consistent with the expression profile analysis. Conclusion: Rare ANGPTL3 variants were identified in Chinese patients with FH, including ANGPTL3: p.(Lys319Arg) which affected the expression of ANGPTL3 and the cholesterol metabolic process as determined by bioinformatics analysis. : Clinical Trial Registration: Chinese Clinical Trial Registration (ChiCTR-ROC-17011027) http://www.chictr.org.cn/listbycreater.aspx
- 28 May 2019
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 25 (2) , 190-200
ANGPTL3 Mutations in Unrelated Chinese Han Patients with Familial Hypercholesterolemia
Background and objective: Familial hypercholesterolemia (FH) is a severe genetic hyperlipidemia characterized by increased levels of low-density lipoprotein cholesterol (LDL-C), leading to premature atherosclerosis. Angiopoietin-like protein (ANGPTL3) is a hepatocyte-specific protein that can be used to lower LDL in FH. However, it was unknown whether ANGPTL3 variants are present in FH patients. This study was performed to identify ANGPTL3 variants in unrelated Chinese Han patients with FH. Methods and Results: We screened 80 patients with FH (total cholesterol >7.8mmol/L, LDL-cholesterol >4.9mmol/L) and 77 controls using targeted next-generation sequencing (NGS) of six FH candidate genes (LDLR, ApoB100, PCSK9, ABCG5, ABCG8, and ANGPTL3). Candidate pathogenic variants identified by NGS were validated by Sanger sequencing. Mutant and wild-type plasmids containing the variant sequence were constructed and verified by Sanger sequencing. The gene expression profile was analyzed by an expression profile chip in transfected HepG2 cells using quantitative real-time (qRT)-PCR. We identified 41 variants in 28 FH patients, including two ANGPTL3 mutations: one exonic (c.A956G: p.K319R) and one in the untranslated region (c.*249G>A). Gene ontology analyses found that the cholesterol metabolic process and ANGPTL3 expression were significantly up-regulated in the ANGPTL3 K319R mutation group compared with the wild-type group. qRT-PCR findings were consistent with the expression profile analysis. Conclusion: Rare ANGPTL3 variants were identified in Chinese patients with FH, including ANGPTL3: p.(Lys319Arg) which affected the expression of ANGPTL3 and the cholesterol metabolic process as determined by bioinformatics analysis. : Clinical Trial Registration: Chinese Clinical Trial Registration (ChiCTR-ROC-17011027) http://www.chictr.org.cn/listbycreater.aspx